Frequency of breast cancer attributable to BRCA1 in a population-based series of American women.
暂无分享,去创建一个
M. King | R. Millikan | P. Moorman | L. Butler | B. Newman | H. Mu | B. Newman | Hua Mu | Mary Claire King | M. King
[1] S. Rubin,et al. Efficacy of screening mammography. A meta-analysis. , 1995, JAMA.
[2] G. Pals,et al. A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. , 1997, American journal of human genetics.
[3] A. Bowcock,et al. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. , 1997, The New England journal of medicine.
[4] K Offit,et al. BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. , 1997, JAMA.
[5] G. Lenoir,et al. Familial breast-ovarian cancer locus on chromosome 17q12-q23 , 1991, The Lancet.
[6] G. Stamatoyannopoulos,et al. Pitfalls of genetic testing. , 1996, The New England journal of medicine.
[7] J. D. Thompson,et al. Germ-line BRCA1 mutations in selected men with prostate cancer. , 1996, American journal of human genetics.
[8] D. Easton,et al. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. , 1995, American journal of human genetics.
[9] K. Johnson,et al. Tamoxifen Breast Cancer Prevention Trial--an update. , 1997, Progress in clinical and biological research.
[10] P. Tonin,et al. Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? , 1997, American journal of human genetics.
[11] B Healy,et al. BRCA genes--bookmaking, fortunetelling, and medical care. , 1997, The New England journal of medicine.
[12] Bernard J. Quinn. Churches and church membership in the United States, 1980 : an enumeration by region, state, and county, based on data reported by 111 church bodies , 1982 .
[13] F. Couch,et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. , 1997, The New England journal of medicine.
[14] C R Weinberg,et al. Randomized recruitment in case-control studies. , 1991, American journal of epidemiology.
[15] J. D. Thompson,et al. BRCA1 mutations in a population-based sample of young women with breast cancer. , 1996, The New England journal of medicine.
[16] K. Kerlikowske,et al. Effect of age, breast density, and family history on the sensitivity of first screening mammography. , 1996, JAMA.
[17] G. Lenoir,et al. A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17. , 1997, Cancer research.
[18] C R Weinberg,et al. The design and analysis of case-control studies with biased sampling. , 1990, Biometrics.
[19] D. Easton,et al. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. , 1993, American journal of human genetics.
[20] S. Cummings,et al. Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer. , 1997, American journal of human genetics.
[21] M. King,et al. Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. , 1998, American journal of human genetics.
[22] N Risch,et al. Genetic analysis of breast cancer in the cancer and steroid hormone study. , 1991, American journal of human genetics.
[23] S. Fletcher,et al. Whither scientific deliberation in health policy recommendations? Alice in the Wonderland of breast-cancer screening. , 1997, The New England journal of medicine.
[24] F. Couch,et al. Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2. , 1996, American journal of human genetics.
[25] A S Whittemore,et al. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer. , 1997, American journal of human genetics.
[26] Patrick Dowd,et al. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families , 1994, Nature Genetics.
[27] M. King,et al. Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. , 1995, American journal of human genetics.
[28] J. Ka,et al. Tamoxifen Breast Cancer Prevention Trial--an update. , 1997 .
[29] H. Mefford,et al. BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2. , 1997, American journal of human genetics.
[30] M. King,et al. Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. , 1996, American journal of human genetics.
[31] D. Easton,et al. Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium. , 1995, American journal of human genetics.
[32] F. Collins. BRCA1--lots of mutations, lots of dilemmas. , 1996, The New England journal of medicine.
[33] M. King,et al. Linkage of early-onset familial breast cancer to chromosome 17q21. , 1990, Science.
[34] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[35] P. Hartge,et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.
[36] A. Sachs,et al. Messenger RNA degradation in eukaryotes , 1993, Cell.
[37] K H Rothenberg,et al. Genetic Information and Health Insurance: State Legislative Approaches , 1995, Journal of Law, Medicine & Ethics.
[38] Barbara L. Smith,et al. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. , 1996, The New England journal of medicine.
[39] Peter Devilee,et al. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients , 1997, Nature Genetics.
[40] M. King,et al. Linkage of familial breast cancer to chromosome 17q21 may not be restricted to early-onset disease. , 1992, American journal of human genetics.
[41] M. Skolnick,et al. Statement of the American Society of Clinical Oncology : Genetic testing for cancer susceptibility. Commentaries , 1996 .
[42] D. Easton,et al. Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.
[43] Troy Duster,et al. Genetic Information and the Workplace: Legislative Approaches and Policy Challenges , 1997, Science.
[44] M. Skolnick,et al. Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations. , 1996, Human molecular genetics.
[45] M. King,et al. Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. , 1988, Proceedings of the National Academy of Sciences of the United States of America.